Moderna Gets $50M for New mRNA Ebola Vaccine

Moderna just landed $50 million from the US government to develop an mRNA vaccine targeting the Bundibugyo strain of Ebola. This is their third Ebola vaccine in the works. The funding comes from the Biden administration's plan to prep for future pandemics. The mRNA tech behind this vaccine is the same that made their COVID-19 shot so effective. Why this matters for us: This could save lives in places like Africa and our own neighborhoods, where Black and Brown communities often get hit first and hardest by outbreaks.